Nevertheless, facts about ADRs weren't available, which limits the full knowledge of the observed large variability in tramadol and ODT exposure and the risk of ADRs. A higher number of participants could improve the ability to characterise interactions involving participant traits and tramadol and also the pharmacokinetic parameters of tramado